Akonni receives $150 arcalion 200mg.

Akonni receives $150,000 Phase We NSF grant to assess feasibility of developing lab-on-a-film microarray device Akonni Biosystems, a molecular diagnostics organization that develops, manufactures, and plans to market sophisticated molecular testing products for diagnosing infectious diseases and individual genetic disorders, announced today the receipt of a $150,000 Phase I Grant from the National Research Foundation . This initial round of funding from NSF will enable Akonni to assess the feasibility of developing a lab-on-a-film microarray device that can be manufactured in a reel-to-reel format. This means that that, with tightening ballooning and budgets projections for diagnostic testing, the next technical revolutions in molecular diagnostics must deliver substantial reductions in per test cost arcalion 200mg .